How Can We Best Diagnose Severity Levels of Dry Eye Disease: Current Perspectives

Thomas Chester; Sumit Sam Garg; Josh Johnston; Brandon Ayers; Preeya Gupta

doi:10.2147/OPTH.S388289

How Can We Best Diagnose Severity Levels of Dry Eye Disease: Current Perspectives

Clin Ophthalmol. 2023 Jun 5:17:1587-1604. doi: 10.2147/OPTH.S388289. eCollection 2023.

Authors

Thomas Chester¹, Sumit Sam Garg², Josh Johnston^{3

4}, Brandon Ayers⁵, Preeya Gupta^{6

7}

Affiliations

¹ Cleveland Eye Clinic, Brecksville, OH, USA.
² Department of Ophthalmology, Gavin Herbert Eye Institute, University of California-Irvine, Irvine, CA, USA.
³ Georgia Eye Partners, Atlanta, GA, USA.
⁴ Southern College of Optometry, Memphis, TN, USA.
⁵ Ophthalmic Partners PC, Cornea Service, Wills Eye Hospital, Philadelphia, PA, USA.
⁶ Triangle Eye Consultants, Raleigh, NC, USA.
⁷ Department of Ophthalmology, Tulane University, New Orleans, LA, USA.

Abstract

Dry eye disease (DED) is a common ocular condition, but the diagnosis relative to other ocular conditions and the evaluation of severity of the condition has often been difficult. This challenge can be due to clinical signs and symptoms not always correlating with each other. An understanding of the various components which create the condition, as well as the diagnostic measures used to evaluate these components, is useful to the clinician working with DED patients. This review paper will discuss traditional diagnostic options, diagnostic imaging, and Advanced Point of Care testing capabilities to determine the severity level of dry eye disease more adequately.

Keywords: POC testing; biomarkers; diagnostic imaging; dry eye disease.

Publication types

Review